CanadaBis Capital Inc.
CanadaBis Capital Inc. (CANB.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
canb.v · pe ratio · data through Jul 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CanadaBis Capital Inc. (CANB.V) measures how much investors pay for each dollar of the company's trailing earnings. CANB.V's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-07-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%9.0x
MedianQ3 · 75%12.7x
Max
At N/A, CANB.V's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CanadaBis Capital Inc.You CANB.V | $2M | N/A | — | -$0.01 |
 Avricore Health Inc. AVCR.V | $5M | N/A | — | -$0.02 |
 Avant Brands Inc. AVNT.TO | $7M | N/A | — | -$0.88 |
 Ayurcann Holdings Corp. AYUR.CN | $2M | N/A | — | -$0.02 |
 CordovaCann Corp. CDVA.CN | $4M | N/A | — | -$0.02 |
 Kane Biotech Inc. KNE.V | $5M | N/A | — | -$0.02 |
 Mercanto Holdings Inc. MUSH.V | $6M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-07-31Latest FY2025 | — | $-0.01 | — | |
2024-07-31 FY2024 | 12.67x | $0.00 | +41.5% | |
2023-07-31 FY2023 | 8.95x | $0.03 | +13.8% | |
2022-07-31 FY2022 | 7.87x | $0.00 | — | |
2021-07-31 FY2021 | — | $-0.02 | — | |
2020-07-31 FY2020 | — | $-0.04 | — | |
2019-07-31 FY2019 | — | $-0.09 | — | |
2018-12-31 FY2018 | — | $-0.02 | — | |
2017-12-31 FY2017 | — | $-0.02 | — | |
2016-11-30 FY2016 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CanadaBis Capital Inc. (CANB.V) measures how much investors pay for each dollar of the company's trailing earnings. CANB.V's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.01.
Frequently asked questions
CANB.V pe ratio · 6 questionsCANB.V's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.01 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via CANB.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CanadaBis Capital Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08